Zohren Fabian 4
4 · Merus N.V. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Merus N.V.MRUS
Zohren Fabian
Chief Medical Officer
Transactions
- Award
Share Options (Right to Buy)
2024-07-01+183,943→ 183,943 totalExercise: $54.45Exp: 2034-06-30→ Ordinary Shares (183,943 underlying)
Footnotes (1)
- [F1]Options vest over a four-year period commencing July 1, 2024. 25% vest after one year and in 36 equal monthly installments thereafter.